Top-News
Biotechnologie USA

Ocugen Inc Aktie

Aktie
WKN:  A2PSZH ISIN:  US67577C1053 US-Symbol:  OCGN
0,71 €
-0,03 €
-4,05%
23.12.24
Handeln Depot/Watchlist
Aktienanzahl *
287,86 Mio.
Marktkapitalisierung *
247,96 Mio. €
Streubesitz
71,07%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.08.2024

Ocugen Inc News

03.11.24 - Börse-Global
Ocugen Aktie: Ein Gewinn für alle!
Ocugen, ein biopharmazeutisches Unternehmen mit Fokus auf Gentherapien für Augenkrankheiten, zeigt in den letzten Wochen eine positive Kursentwicklung. Die Aktie konnte im ...
24.10.24 - Boersia.de
Ocugen Aktie: Fortschritte in Phase 2 Studie
Ocugen, Inc. (NASDAQ: OCGN) verzeichnet einen bedeutenden Meilenstein in seiner klinischen Forschung. Das Biotechnologieunternehmen erhielt kürzlich die Genehmigung des ...
23.10.24 - Boersia.de
Ocugen Aktie: Kursrückgang trotz vielversprechender Entwicklungen
Die Ocugen Aktie verzeichnete kürzlich einen leichten Rückgang, wobei der Kurs am 23. Oktober 2024 bei 0,93 USD lag. Dies entspricht einem Minus von 0,90% gegenüber dem ...
20.08.24 - PR Newswire
Ocugen, Inc. Investor Alert (NASDAQ: OCGN): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors Following Earnings Restatement and Possible Insider Trading
Ocugen, Inc. Investor Alert (NASDAQ: OCGN): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors Following Earnings ...
07.06.24 - PR Newswire
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit PR Newswire
06.06.24 - PR Newswire
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit PR Newswire
06.06.24 - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen PR Newswire
04.06.24 - PR Newswire
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm PR Newswire
04.06.24 - PR Newswire
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit PR Newswire
03.06.24 - PR Newswire
OCGN DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN
OCGN DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed ...
31.05.24 - PR Newswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen PR Newswire
30.05.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN PR Newswire
24.05.24 - PR Newswire
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm PR Newswire
24.05.24 - PR Newswire
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit PR Newswire
24.05.24 - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen PR Newswire
23.05.24 - PR Newswire
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit PR Newswire
22.05.24 - PR Newswire
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit PR Newswire
17.05.24 - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen PR Newswire
15.05.24 - PR Newswire
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm PR Newswire
10.05.24 - PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN PR ...

Newssuche

Videos

13:40 Uhr -2,73%
Aktien & Gold - Quo vadis 2025?
Das Jahr 2024 neigt sich dem Ende entgegen und 2025 steht vor der Tür. Warum 2025 für Aktien ein ... Mehr »
Anzeige

Aktie im Fokus

Die strategische TRUMP-Aktie
European Lithium Ltd
0,0204 €
-0,97%
European Lithium Ltd Realtime-Chart
548 % Kurspotenzial
Mehr zur Aktie »